Leading fund manager Karst Peak Capital has secured a significant interest in a little-known Aussie pharmaceuticals research company, following the significant success they experienced with a large holding of Avita Medical. Originally based in Hong Kong but now also with an office in Sydney, Karst’s investment focus includes the healthcare, biotech and pharmaceuticals industry which
Read More
Continued emergence of graphene and its application in biotech is being led by homegrown tech company Archer Materials (ASX: AXE) which has secured access to a $150 million world-class research facility to advance their biochip development. The facility provides Archer with instruments to test its semiconductor device production processes. Key to the deep tech access
Read More
While we are seemingly on the back-stretch of the COVID-19 pandemic, increased medical awareness has changed how we diagnose respiratory diseases with medtech company 4DMedical (ASX: 4DX) leading the charge. Their proprietary FDA/TGA approved, patented respiratory imaging platform, XV Technology turns sequences of x-ray images into four-dimensional, quantitative data to improve and accelerate diagnostic accuracy.
Read More
One of the hottest retail stocks on the ASX with gains of more than 300% over the past year, Harris Technology (ASX: HT8) is showing no signs of slowing down with investors rushing to fund further growth as HT8 successfully completed an oversubscribed $5 million capital raise. The funding was supported by institutional and professional
Read More
When customers are more than happy to pay upwards of $5 for a cup of coffee in major Australian cities, it’s fair to say there’s a bit of money to be made in the market where tech company Rewardle (ASX: RXH) is taking a unique approach by investing in their customers. Taking their Rewardle app
Read More
Bringing telehealth to expectant mothers that will rival major hospital facilities, medtech company HeraMED (ASX: HMD) is taking a significant step forward in the commercialisation of their foetal monitoring device. As part of their Technology as a Service (TaaS) recurring revenue model, the Company has entered into an agreement with Joondalup Health Campus (JHC) which
Read More
As the world becomes more accepting of medicinal cannabis, hemp has been another big winner in terms of marketability which has led nutraceuticals company Live Verdure (ASX: LV1) to the United States which is the world’s largest market for such products. Owners of the hemp-based food brands “13 Seeds” and “8 Seeds” which originate from
Read More
Intelligent traffic is all the rage across the developed world with the world’s most progressive nations leading the way, placing orders with smart city tech company Traffic Technologies (ASX: TTI) for $1.7 million worth of equipment. The contract orders will send more than 300 Urban traffic controllers to China, Singapore, Qatar and Chile which utilise
Read More
A listed fintech company that simplifies back office functions for accountants and financial advisers doesn’t exactly have the same investor ‘sex appeal’ as neo banks, bitcoin players or the buy-now-pay-later sector. But that doesn’t mean it won’t generate exciting returns for investors. A giant in the self managed super funds (SMSF) administration sector, Class Limited
Read More
Working in conjunction with the CSIRO, Anatara Lifesciences (ASX: ANR) has received ethics approval to apply their diet supplement 3FDC to a new area of medicine, seeking to evaluate the compound’s effects in adults with moderate anxiety, stress and depression. 3FDC is one of the constituents of Anatara’s flagship supplement (GaRP) intended for the treatment
Read More
